Literature DB >> 8869836

Epidemiology and control of multiresistant enterococci.

R Leclercq1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8869836     DOI： 10.2165/00003495-199600522-00010

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  11 in total

Review 1.  Beta-lactamase-producing enterococci.

Authors:  B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

2.  The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options.

Authors:  R C Moellering
Journal:  J Antimicrob Chemother       Date:  1991-07       Impact factor: 5.790

3.  Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study.

Authors:  M J Zervos; C A Kauffman; P M Therasse; A G Bergman; T S Mikesell; D R Schaberg
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

Review 4.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 5.  Genetics and mechanisms of glycopeptide resistance in enterococci.

Authors:  M Arthur; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

Review 6.  Recommendations for preventing the spread of vancomycin resistance.

Authors: 
Journal:  Infect Control Hosp Epidemiol       Date:  1995-02       Impact factor: 3.254

7.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

8.  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-08-06       Impact factor: 17.586

9.  Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium.

Authors:  R Fontana; M Aldegheri; M Ligozzi; H Lopez; A Sucari; G Satta
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

10.  Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group.

Authors:  R N Jones; H S Sader; M E Erwin; S C Anderson
Journal:  Diagn Microbiol Infect Dis       Date:  1995-02       Impact factor: 2.803
View more
  2 in total

1.  Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in southern Israel.

Authors:  N Marcus; N Peled; P Yagupsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

Review 2.  Colonisation and infection with resistant gram-positive cocci. Epidemiology and risk factors.

Authors:  O Cars
Journal:  Drugs       Date:  1997       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.